Search
Search
Close this search box.

Up in Arms with Pure Sunfarms

This week, Pure Sunfarms complained to Health Canada that one of their competitors was fudging the THC content on their labels. That competitor was none other than the 800 pound cannabis gorilla Canopy Growth. So this was no small thing.

After that formal complaint with Health Canada Pure Sunfarms President and CEO Mandesh Dosanjh took to LinkedIn to dive a little deeper.

Misleading labelling?

Health Canada requires all products to be clearly labelled with cannabinoid content, some companies save money through “static labelling” — printing a range that reflects the potential of what’s inside, he explained. Others, like Pure Sunfarms, print the exact number that came back with each batch. 

Some Canopy products, the complaint alleges, are labelled with the mid-point within the potential range. Dosanjh said this approach misleads the customer into thinking the THC content on the label is accurate, rather than an estimation. A bad experience for customers and competitors alike.

Dynamic dialogue

Dosanjh urged consumers and industry reps to weigh in on the issue. “It’s important that we take action or risk losing consumer confidence in all regulated product,” he wrote in his LinkedIn post. “At a time when this industry is doing so much to try to combat the illicit market, why are we pulling back in the shadows?” 

What’s next

In an emailed statement, Canopy told BNN Bloomberg that their labels are compliant. Health Canada said they would investigate and take appropriate action if deemed necessary. Well, we’re waiting…


🔒 Risk Management Report • Produced in partnership with RELM
Prohibition Partners RELM
📊 New Report Available Now

Relm Risk Briefing: Cannabis 2026

The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.

What's covered

  • 🌱 Cultivation risk management — biological contamination, environmental instability, and security protocols
  • ⚗️ Manufacturing & extraction — GMP standards, in-house testing, and quality control measures
  • 🔬 Testing & compliance — rigorous protocols ensuring product safety and regulatory adherence
  • 📦 Distribution & logistics — GDP-aligned transport, route monitoring, and cargo insurance
Key focus areas
Cultivation Manufacturing Testing & QC Packaging Distribution Retail & Pharmacy
100% free • Comprehensive risk analysis

Key insights

Industry Maturity Cannabis has evolved from patchwork markets to international enterprise, with risk management now the measure of long-term stability.
Cultivation Challenges Operators addressing biological contamination through controlled-environment agriculture, tissue culture, and IPM protocols.
Quality Control GMP adherence, in-house testing, and selective supplier relationships emerging as critical control points.
Supply Chain Security GDP-aligned transport, route monitoring, and comprehensive insurance remain essential safeguards.
Market Access Initiatives stabilizing domestic supply and expanding pharmacy training improving patient and consumer access.
Produced by Prohibition Partners in collaboration with RELM—the only insurer dedicated to emerging industries like cannabis.
Partnership
Produced by Prohibition Partners in collaboration with RELM

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?